Yamido, Rein .
HRN: 23-76-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/27/2024
01/03/2025
IV
70mg
Q8h
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes